22nd Century Group Stock News

(RTTNews) - The U.S. Food and Drug Administration has authorized the marketing of 22nd Century Group Inc.''s (XXII) VLN King and VLN Menthol King reduced nicotine content cigarettes as modified risk tobacco products, the company said in a statement. The FDA found that VLN - which smokes, tastes, and smells like a conventional cigarette but

VLN Is World''s First and Only Combustible Cigarette to Receive FDA MRTP DesignationFDA Adds Evidence-Based, Headline Claim "Helps You Smoke Less" to Company''s Requested Claims VLN 95% Reduced Nicot

The biotech wants to help smokers quit.

Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today.

https://www.investing.com/news/stock-market-news/22nd-century-shares-pop-on-fda-marketing-authorization-2722585

BUFFALO, N.Y., Dec. 23, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the Companys VLN® King and VLN® Menthol King reduced nicotine content cigarettes as modified risk tobacco products (MRTPs). In doing so, the Agency found that VLN® which smokes, tastes, and smells like a conventional cigarette but contains 95% less nicotine than conventional, highly addictive cigarettes help reduce exposure to, and consumption of, nicotine for smokers who use them.

The biotech wants to help smokers quit.

In last trading session, 22nd Century Group Inc. (NASDAQ:XXII) saw 1.26 million shares changing hands with its beta currently measuring 1.85. Companys recent per share price level of $2.20 trading at -$0.01 or -0.45% at ring of the bell on the day assigns it a market valuation of $350.39M. That closing price of XXIIs stock 22nd Century Group Inc. (NASDAQ:XXII) -4.35% Down Over Last Week, What Happens Next? Read More »

22nd Century Group Inc. received regulatory authorization to start advertising its cigarettes as low in nicotine -- a move that could shake up the shrinking tobacco market.

22nd Century Group Rallies 55% Over FDA Approval To Market Its VLN Cigarettes In The U.S.

Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today.

22nd Century Group Inc. (NASDAQ:XXII) traded at $2.21 at close of the session on Tuesday, 12/21/21, made an upward move of 3.27% on its previous days price. Looking at the stock we see that its previous close was $2.14 and the beta (5Y monthly) reads 1.81 with the days price range being $2.135 $2.25. 22nd Century Group Inc. (NASDAQ: XXII) Analysts Revisions Show Sentiment Is Improving Read More »